CAI, SUI XIONG,TIAN, YE, EDWARD,DONG, HAIJUN,XU, QINGBING,WU, LIZHEN,LIU, LIJUN,JIANG, YANGZHEN,BAO, QINGLI,WANG, GUOXIANG,YIN, FENG,GU, CHENGYUN,HU, XIUHUA,WANG, XIAOZHU,KANG, SISHUN,CHEN, SHENGZHI
申请号：
RSP20190877
公开号：
RS59091B1
申请日:
2012.03.31
申请国别(地区):
RS
年份:
2019
代理人:
摘要：
Disclosed are 1-(arylmethyl)quinazoline-2,4(1H,3H)-diones thereof, represented by the Formula (I) wherein Ar, R1-R6 are defined herein. Compounds having Formula (I) are PARP inhibitors. Therefore, compounds of the invention may be used to treat clinical conditions that are responsive to the inhibition of PARP activity.
